Clinical Trials Logo

Filter by:
NCT ID: NCT05909904 Recruiting - Clinical trials for Head and Neck Cancer

Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

Start date: July 21, 2023
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the efficacy and safety of tislelizumab and tislelizumab in combination with investigational agent(s) in first-line recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

NCT ID: NCT05907122 Recruiting - Melanoma Clinical Trials

A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

Start date: July 26, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the pharmacokinetic (PK) similarity and efficacy, safety, and immunogenicity of ABP 206 compared with OPDIVO® (nivolumab) in subjects with resected advanced melanoma.

NCT ID: NCT05904886 Recruiting - Clinical trials for Carcinoma, Hepatocellular

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152)

SKYSCRAPER-14
Start date: September 14, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in combination with atezolizumab and bevacizumab as first-line treatment, in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC).

NCT ID: NCT05901961 Completed - Clinical trials for Fungal Foot Infection

Effectiveness and Safety of Whitfield's Solution, Zinc Oxide Nanoparticles Solution or Combination for the Treatment of Fungal Feet Infection

WhitfieldZinc
Start date: June 2, 2023
Phase: Phase 4
Study type: Interventional

This study aimed to study the efficacy of Whitfield's solution, zinc oxide nanoparticles solution, and the combination of Whitfield's and zinc oxide nanoparticles solution in treating fungal feet infection.

NCT ID: NCT05901376 Recruiting - Gastric Cancer Clinical Trials

MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection

Start date: April 25, 2023
Phase:
Study type: Observational

The goal of this observational study is to compare specific microRNA levels from the plasma of gastric cancer patients and healthy volunteers to see if there is an upregulated expression in gastric cancer patients. The main question it aims to answer is: - Can microRNAs be effectively used as diagnostic biomarkers for gastric cancer? Participants will be asked for their consent to obtain 5 cc of blood.

NCT ID: NCT05895955 Active, not recruiting - Influenza Clinical Trials

Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais

Start date: November 4, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The study is aim to evaluate the safety and immunogenicity of one dose TetraFluvac TF vaccine (15 μg HA per strain per dose) of the GPO seasonal quadrivalent inactivated split virion influenza vaccine in healthy adults aged 18 years and above over 90 days post-injection.

NCT ID: NCT05894213 Completed - Sarcopenia Clinical Trials

Prevalence and Factors Associated With Sarcopenia in Pre-retirement Aged Adults With Chronic Non-specific Lower Back Pain

Start date: July 1, 2019
Phase:
Study type: Observational

To study the prevalence of sarcopenia in a pre-retirement group with chronic lower back pain and factors associated between sarcopenia and chronic lower back pain in the pre-retirement group.

NCT ID: NCT05884905 Recruiting - Renal Insufficiency Clinical Trials

Safety of Short Hydration Method for Cisplatin Administration Compared With Conventional Hydration

Start date: March 7, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate safety of short hydration with cisplatin administration. The main outcome is renal dysfunction following cisplatin use with short hydration protocol. Another group of patients received conventional hydration is the historical control for comparison (Randomized phase II design with a reference standard treatment control arm)

NCT ID: NCT05880589 Recruiting - Lactation Clinical Trials

Efficacy and Safety of Milk Secretory Supplement in Breast-feeding Volunteers

Start date: December 8, 2022
Phase: N/A
Study type: Interventional

The objective of this study are to evaluate efficacy and safety of milk secretory supplement containing fenugreek, banana flower, and ginger extract in breast-feeding volunteers

NCT ID: NCT05878379 Completed - Clinical trials for Iron Deficiency, Anaemia in Children

Effect of a Dietary Iron Program on Iron Status and IQ in Children in Phatthalung Province, Thailand

Start date: May 2, 2018
Phase: N/A
Study type: Interventional

Iron deficiency (ID) continues to be one of the most prevalent disorders, which can adversely affect cognitive ability in childhood. Our aim was to determine the effect of a dietary iron education program (DIP) on children's iron status and intelligence quotient (IQ) score. This pre-test (week 1) post-test (week 16) quasi-experimental study with follow-up (week 18) utilized constructs from the Health Belief Model. Children and caregivers participated in the DIP which incorporated group talks, presentations, brainstorming, game-based learning and cooking sessions from weeks 2-15. Knowledge of ID and dietary iron, perceived susceptibility and severity, benefits and barriers for changing behavior, dietary intake, iron status and IQ score were determined at all timepoints (weeks 1, 16, and 18).